Search Results
Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD
steps." On this news, Aardvark's stock price fell $7.02 per share, or 56.2%, to close at $5.47 per share on March 2, 2026.Then, on May 14, 2026, Aardvark issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) has placed a full clinical hold on its investigational
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Datavault AI Inc. and Certain Officers - DVLT
times.The truth began to emerge on October 31, 2025, when Wolfpack Research published a short report on Datavault AI (the "Wolfpack Report"). The Wolfpack Report alleged, among other things, that Datavault AI was a "stock promotion" that relied on misleading press releases and "empty
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fractyl Health, Inc. and Certain Officers - GUTS
Fractyl's stock price fell $1.245 per share, or 68.03%, to close at $0.585 per share on January 29, 2026.The same day, during post-market hours, Canaccord Genuity issued a report on Fractyl, providing additional color on the site-specific issue identified by Defendant Rajagopalan. Specifically, the
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against AST SpaceMobile, Inc. and Certain Officers - ASTS
reported sale price of AST SpaceMobile's Class A common stock on February 11, 2026."Following these disclosures, AST's Class A common stock price fell $14.70 per share, or 15.17%, to close at $82.22 per share on February 12, 2026. Then, on July 15, 2026, AST issued a press release "announc[ing]
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against AppLovin Corporation and Certain Officers - APP
Accordingly, based on a "slower initial GA ramp", Bank of America Securities lowered its expectations of AppLovin's annual revenue.Following publication of the note, AppLovin's stock price fell $64.13 per share, or 12.65%, to close at $442.85 per share on July 13, 2026.Then, on August 5, 2026,
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces The Filing of a Class Action Against Celsius Holdings, Inc. and Certain Officers - CELH
response, inter alia, "our policy is not to market or sample to anyone under 18".On this news, Celsius's stock price fell $1.52 per share, or 4.18%, to close at $34.86 on April 10, 2026.Then, on June 4, 2026, Texas Attorney General Ken Paxton ("Paxton") announced an investigation into
More news about: Pomerantz LLP
Sep 24, 2026, 17:37 ET Bluerock Acquisition Corp. II Announces Pricing of $150 Million Initial Public Offering
initial public offering of 15,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global Market ("Nasdaq") and are expected to trade under the ticker symbol "BRRKU" beginning on September 25, 2026. Each unit consists of one Class A ordinary share and one-half of one redeemable
More news about: Bluerock Acquisition Corp. II
Sep 24, 2026, 17:35 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lincoln Educational Services Corp. of Class Action Lawsuit and Upcoming Deadlines - LINC
growing 9%, "as fewer enrolled students than expected attended the first day of class." On this news, Lincoln Educational's stock price fell $10.22 per share, or 24.93%, to close at $30.77 per share on August 10, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
2 mg aflibercept (Regeneron Pharmaceuticals' (REGN) Eylea) was not met in the entire dataset. On this news, EyePoint's stock price fell $9.88 per share, or 66.98%, to close at $4.87 per share on August 17, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
of 2026, in fact remained unresolved and was now expected to persist into the fourth quarter. On this news, Stryker's stock price fell $26.70 per share, or 8.81%, to close at $276.43 per share on September 8, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ServiceTitan, Inc. - TTAN
this fiscal year, which, of course, also flows through to professional services gross margin."On this news, ServiceTitan's stock price fell $24.46 per share, or 29.98%, to close at $57.12 per share on September 9, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
action]On August 24, 2026, Azenta issued a press release announcing the resignation of John Marotta from his roles as Chief Executive Officer and as a director of the Company. On this news, Azenta's stock price fell $4.52 per share, or 12.09%, to close at $32.88 per share on August 24, 2026.Pomerantz
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of lululemon athletica inc. - LULU
social-media commentary, softer-than-planned new-product launches, and weaker store traffic. On this news, lululemon's stock price fell $21.16 per share, or 17.38%, to close at $100.61 per share on September 4, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
score nor the key secondary endpoint of net response in Multidomain Responder Index (MDRI)." On this news, Ultragenyx's stock price fell $11.68 per share, or 44.03%, to close at $14.85 per share on September 3, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
alanine transaminase (ALT) and/or aspartate aminotransferase (AST) elevations were also observed." On this news, Beam's stock price fell $2.83 per share, or 9.54%, to close at $26.83 per share on September 8, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - OSIS
action]On August 20, 2026, OSI reported fiscal fourth-quarter and full-year 2026 financial results, including revenue that fell short of consensus expectations. OSI attributed the revenue miss to deferred product deliveries stemming from site constraints. On this news, OSI's stock
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EHang Holdings Limited - EH
and affected the pace of passenger commercial operation approvals in certain regions." On this news, EHang's American Depositary Share ("ADS") price fell $0.37, or 7.12%, to close at $4.83 per ADS on August 25, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LENZ Therapeutics, Inc. ("Lenz" or the "Company") (NASDAQ: LENZ). Such investors are advised to contact Danielle Peyton at
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qfin Holdings, Inc. - QFIN
funding costs and systemic liquidity shocks in the Chinese consumer credit market. On this news, Qfin's American Depositary Receipt ("ADR") price fell $2.18 per ADR, or 18.91%, to close at $9.35 per ADR on August 26, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION
sweat chloride when SION-719 was administered alongside the standard-of-care treatment Trikafta. On this news, Sionna's stock price fell $46.54 per share, or 91.18%, to close at $4.50 per share on August 10, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
joining the class action]On August 10, 2026, AirSculpt announced its financial results for the second quarter of fiscal 2026. The Company reported revenue of $42.9 million, down from $44.0 million in the same period in the prior year. On this news, AirSculpt's stock price fell
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO
[Click here for information about joining the class action]On August 13, 2026, Abeona issued a press release "report[ing] financial results for the second quarter of 2026 and provid[ing] an update on commercial execution for ZEVASKYN (prademagene zamikeracel)." Abeona disclosed that
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Klarna Group plc - KLAR
[Click here for information about joining the class action]On or around September 10, 2025, Klarna completed its initial public offering ("IPO"), selling 34.3 million shares priced at $40.00. Then, on August 18, 2026, Klarna announced its financial results for the second quarter of
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. - SEDG
action]On August 5, 2026, SolarEdge reported its financial results for the second quarter of 2026. Among other items, SolarEdge forecasted Q3 2026 revenue in the range of $310 million to $340 million, well below the consensus analyst estimates of around $371 million. On this news, SolarEdge's
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of JinkoSolar Holding Co., Ltd. - JKS
2025, discussing the Company's third quarter financial results. On this news, JinkoSolar's American Depositary Receipt ("ADR") price fell $2.88 per ADR, or 11.89%, to close at $21.34 per ADR on April 16, 2026. Then, on August 26, 2026, JinkoSolar reported its financial results for the second
More news about: Pomerantz LLP